Table 1.
Literature review of venous Port implantation through PLSVC
| Year | Author(s) | n | Age (years) |
Gender | Diagnosis | Azygos Vein Variation | Port Duration | Port-a-Cath Related Complications | PLSVC Type |
|---|---|---|---|---|---|---|---|---|---|
| 2003 | Laurenzi et al. [3] | 1 | 59 | Male | Lung cancer | N/A | 8 months | None | II |
| 2010 | Dinasarapu et al. [19] | 1 | 52 | Female | Right breast cancer | N/A | 2 cycles of chemotherapy | Postoperative fever, leukopenia, and recurrent neurological symptoms associated with the use of the port-a-cath, considered to be related to microthrombus detachment or air embolism. | IIIb |
| 2011 | Povoski et al. [9] | 1 | 53 | Female | Bilateral breast cancers | N/A | about 7 months | None | IIIb |
| 2016 | Zhou et al. [10] | 1 | 37 | Female | Non-Hodgkin lymphoma | N/A | 8 months | None | N/A |
| 2016 | Sarsenov et al. [11] | 1 | 35 | Female | Right breast cancer | N/A | N/A | None | IIIb |
| 2016 | Konstantinou et al. [17] | 1 | 63 | Male | Metastatic colon cancer | N/A | Removed after implantation | N/A | IIIb |
| 2017 | Evers et al. [16] | 1 | 50 | N/A | Adenocarcinoma of the esophagus | N/A | 8 cycles of chemotherapy | None | IIIb |
| 2018 | Van Walleghem et al. [12] | 1 | 74 | Male | Lung cancer | N/A | N/A | None | IIIb |
| 2021 | Jheengut et al. [15] | 8 | average 44.8 (range 31–59) | 6 females; 2 males | 6 cases of breast cancer, 2 cases of non-small cell lung cancer | N/A | 6–20 cycles of chemotherapy (varying for each patient) | None | N/A |
| 2022 | El-Helou et al. [13] | 1 | 40 | Male | Mixed Hodgkin lymphoma | N/A | 9 months | None | IIIa |
| 2022 | Zhou et al. [14] | 2 | 40 and 54 | Female | 40y-Bilateral breast cancers; 54y- Right breast cancer | N/A | Completion of chemotherapy | None | 40y-IIIa; 54y-N/A |
| 2023 | Bonitto et al. [8] | 1 | 5 | Female | Long-chain L-3 hydroxyacylCoA dehydrogenase deficiency | N/A | 3 years | Catheter dysfunction | N/A |
| 2023 | Masaki et al. [18] | 1 | 85 | Female | Dysphagia due to the after-effects of cerebral infarction | N/A | Removed after implantation | N/A | IIIb |
| 2024 | Hama et al. [7] | 1 | 33 | Female | Right breast cancer | N/A | 8 months | Catheter dysfunction and malposition | IIIb |